It was reported that in other types of human cancer, such as breast, prostate, liver and nasopharyngeal cancers, down-regulated expression of Beclin 1 was also frequently observed [6], [21], [25], [27], [37]. This evidence concerns the gene BECN1 and nasopharyngeal carcinoma.